DNA methylation as a target of epigenetic therapeutics in cancer.
about
Long noncoding RNAs-related diseases, cancers, and drugsImmortality of cell lines: challenges and advantages of establishmentHPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.MicroRNA-148b Acts as a Tumor Suppressor in Cervical Cancer by Inducing G1/S-Phase Cell Cycle Arrest and Apoptosis in a Caspase-3-Dependent MannerSpecific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor GrowthEpigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.Adoptive immunotherapy for cancer.Developmental ORIgins of Healthy and Unhealthy AgeiNg: the role of maternal obesity--introduction to DORIAN.Epigenetic alterations in cancer and personalized cancer treatment.DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.Combined analysis of DNA methylation and cell cycle in cancer cells.Methylation status of promoter 1 region of GDNF gene in human glioma cells.Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.Oxygen nanobubbles revert hypoxia by methylation programming.The relative contribution of DNA methylation and genetic variants on protein biomarkers for human diseasesGene Expression Status and Methylation Pattern in Promoter of P15INK4b and P16INK4a in Cord Blood CD34 (+) Stem CellsGenotoxicity kinetics in murine normoblasts as an approach for the in vivo action of difluorodeoxycytidine.Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.
P2860
Q26824697-AB2C56C1-FA51-4C4C-96CA-7E90CDCE53DEQ28291729-0CC6B4E5-DCF1-4282-BF2B-320200582377Q34998465-D90B8259-2E31-4E85-B1E9-981B36567BD5Q37170620-CD565C1F-DCDA-4D9A-972C-DD64167FFA4AQ37290420-6E3E080C-7EAB-4828-BF9A-895E46626CA4Q37719054-55604DB1-C7C6-49BB-91A4-0BE7BA8CBD11Q38170496-00A2AA70-B99C-48E0-B4F0-9E866E214EA1Q38209730-0E5A640C-B705-4030-9B2D-7BA6D4C53105Q38319591-7B183779-49E0-424D-9D8E-CBA570CB03C7Q38790387-D59F1809-843C-4496-A49E-A9FE33807CDBQ38926364-264BA9C9-EBBE-4E26-9E9A-CBE8E174D5AEQ38965786-D93A89A8-1AB1-4B51-83AB-9302894D80FAQ39139077-7C269B5E-6300-4E8D-A9F6-C1360DF29486Q41516085-D54D1C46-21B1-493F-98FF-FF116140813DQ42280727-60818E9B-F700-4747-8E5A-FF2832460D9FQ42577940-23053411-5C67-4072-A52F-1D189D2B7D21Q50785086-5A8DB6F4-0A24-450C-ABDB-7A50D256B317Q55267254-DAC08AD0-6179-495E-A9FC-26ECCA289EDB
P2860
DNA methylation as a target of epigenetic therapeutics in cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
DNA methylation as a target of epigenetic therapeutics in cancer.
@en
type
label
DNA methylation as a target of epigenetic therapeutics in cancer.
@en
prefLabel
DNA methylation as a target of epigenetic therapeutics in cancer.
@en
P2093
P1476
DNA methylation as a target of epigenetic therapeutics in cancer.
@en
P2093
Bilian Jin
Fangcheng Li
Keqin K Li
Qiushi S Li
P304
P356
10.2174/1871520611313020009
P577
2013-02-01T00:00:00Z